Amyloidosis clinical trials at UCSF

1 in progress, 0 open to eligible people

CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
Sorry, not currently recruiting here
Open-label Phase 1b/2 study with primary objective of this study is to evaluate the safety, tolerability and efficacy of AZD0120 in participants with light chain (AL) amyloidosis.
San Francisco 5391959, California 5332921 and other locations

Last updated: September 2, 2025